GMED News and Press, Globus Medical Inc. Class A From 01/11/24

2024-01-11 12:30:01 ET Truist Financial analyst issues BUY recommendation for GMED on January 11, 2024 01:00PM ET. The previous analyst recommendation was Buy. GMED was trading at $57.105 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...

2024-01-10 16:34:03 ET More on Globus Medical Globus Medical: Merger Overhang Lingering Globus Medical Non-GAAP EPS of $0.57 in-line, revenue of $383.64M misses by $54.58M Roth MKM starts Globus Medical at buy, calls it "dominant force in spine" Seeking Alpha...

(NewsDirect) Welcome to the transformative landscape of orthobiologics, where cutting-edge treatments utilize the body's own cells and healing factors to reverse orthoarthritis effects and expedite recovery from tendon and ligament injuries. These innovations, naturally derived and featuring ...

2023-12-11 10:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-03 17:58:12 ET More on Novo Nordisk, Stryker, etc. Why Stryker Is An Awesome Healthcare Compounder Stryker Corporation (SYK) 6th Annual Evercore ISI HealthCONx Conference (Transcript) Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation N...

2023-11-27 18:05:47 ET Summary Globus Medical, Inc., a mid-cap medical device company, has seen its stock decline by over 35% in 2023 due mainly to its merger with Nuvasive. While the combination gives Globus Medical an over 20% market share in a growing market, analyst firms are ...

2023-11-07 22:01:03 ET Globus Medical, Inc. (GMED) Q3 2023 Earnings Conference Call November 07, 2023, 16:30 ET Company Participants Brian Kearns - SVP, Business Development & IR Daniel Scavilla - President, CEO & Director Keith Pfeil - SVP & CFO ...

2023-11-07 20:45:18 ET Image source: The Motley Fool. Globus Medical (NYSE: GMED) Q3 2023 Earnings Call Nov 07, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Globus Medical (GMED) Q3 2023 Earnings Call Transcript

2023-11-07 16:32:28 ET More on Globus Medical Globus Medical: Almost Having My Back Roth MKM starts Globus Medical at buy, calls it "dominant force in spine" Globus Medical completes merger with NuVasive Seeking Alpha’s Quant Rating on Globus Medical ...

AUDUBON, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2023. The merger with NuVasive, Inc. was completed on September 1, 2023 and results presen...